SureTrader Nadex Advertisement
Home > Boards > US OTC > Medical - Drugs > Elite Pharmaceuticals (ELTP)

And, of course, different products, and just launched

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Drugdoctor Member Profile
Member Level 
Followed By 1,251
Posts 95,712
Boards Moderated 9
Alias Born 09/11/05
160x600 placeholder
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/9/2017 4:46:25 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 2/9/2017 4:35:32 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/9/2017 4:34:39 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 12/22/2016 5:25:52 PM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 12/22/2016 5:17:13 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 11/17/2016 4:05:38 PM
Amended Quarterly Report (10-q/a) "Edgar (US Regulatory)" - 11/17/2016 4:03:30 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 11/9/2016 5:10:17 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 11/9/2016 4:42:48 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 9/1/2016 4:32:35 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/31/2016 4:19:33 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/19/2016 5:48:03 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/9/2016 5:30:55 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 8/9/2016 5:28:23 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/9/2016 4:15:19 PM
Four Trending Stocks Leading Biotech Sector on Heels of Latest R&D and Innovative Drug Therapy Advancements "InvestorsHub NewsWire" - 7/27/2016 9:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/21/2016 11:47:37 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/21/2016 7:16:35 AM
Friendable, Inc. (OTC Pink: FDBL) – Ramps Up Infrastructure To Accommodate Growth "InvestorsHub NewsWire" - 7/19/2016 8:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/15/2016 5:27:18 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/15/2016 5:26:22 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 7/14/2016 10:00:28 AM
Notice of Effectiveness (effect) "Edgar (US Regulatory)" - 7/14/2016 6:01:45 AM
Confidential Treatment Order (ct Order) "Edgar (US Regulatory)" - 7/11/2016 1:21:37 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 7/11/2016 10:15:31 AM
Drugdoctor Member Level  Saturday, 06/09/12 10:31:47 PM
Re: dr_lowenstein post# 18518
Post # of 244180 
And, of course, different products, and just launched products, compared to established products that FDA pulled through no fault of ELTP's... But you know that... Yes, I see 50 million dollars annual revenues coming soon for ELTP! How nice is that?

SureTrader
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist